0000000000581489

AUTHOR

C. Miller

showing 7 related works from this author

Search for an Invisibly Decaying Z′ Boson at Belle II in e+e−→μ+μ−(e±μ∓) Plus Missing Energy Final States

2020

Theories beyond the standard model often predict the existence of an additional neutral boson, the Z′. Using data collected by the Belle II experiment during 2018 at the SuperKEKB collider, we perform the first searches for the invisible decay of a Z′ in the process e+e-→μ+μ-Z′ and of a lepton-flavor-violating Z′ in e+e-→e±μZ′. We do not find any excess of events and set 90% credibility level upper limits on the cross sections of these processes. We translate the former, in the framework of an Lμ-Lτ theory, into upper limits on the Z′ coupling constant at the level of 5×10-2-1 for MZ′≤6 GeV/c2.

PhysicsCoupling constantParticle physicsMissing energyPhysics beyond the Standard ModelGeneral Physics and Astronomy01 natural scienceslaw.inventionlaw0103 physical sciencesHigh Energy Physics::Experiment010306 general physicsColliderBosonPhysical Review Letters
researchProduct

Search for Axionlike Particles Produced in e+e− Collisions at Belle II

2020

We present a search for the direct production of a light pseudoscalar a decaying into two photons with the Belle II detector at the SuperKEKB collider. We search for the process e+e-→γa, a→γγ in the mass range 0.2<ma<9.7 GeV/c2 using data corresponding to an integrated luminosity of (445±3) pb-1. Light pseudoscalars interacting predominantly with standard model gauge bosons (so-called axionlike particles or ALPs) are frequently postulated in extensions of the standard model. We find no evidence for ALPs and set 95% confidence level upper limits on the coupling strength gaγγ of ALPs to photons at the level of 10-3 GeV-1. The limits are the most restrictive to date for 0.2<ma<1 GeV/c2.

PhysicsRange (particle radiation)Particle physicsGauge bosonLuminosity (scattering theory)Photon010308 nuclear & particles physicsGeneral Physics and Astronomy01 natural scienceslaw.inventionStandard ModelPseudoscalarDirect productionlaw0103 physical sciencesHigh Energy Physics::Experiment010306 general physicsColliderPhysical Review Letters
researchProduct

Precise Measurement of the D0 and D+ Lifetimes at Belle II

2021

We report a measurement of the D^{0} and D^{+} lifetimes using D^{0}→K^{-}π^{+} and D^{+}→K^{-}π^{+}π^{+} decays reconstructed in e^{+}e^{-}→cc[over ¯] data recorded by the Belle II experiment at the SuperKEKB asymmetric-energy e^{+}e^{-} collider. The data, collected at center-of-mass energies at or near the ϒ(4S) resonance, correspond to an integrated luminosity of 72  fb^{-1}. The results, τ(D^{0})=410.5±1.1(stat)±0.8(syst)  fs and τ(D^{+})=1030.4±4.7(stat)±3.1(syst)  fs, are the most precise to date and are consistent with previous determinations.

PhysicsParticle physics010308 nuclear & particles physicslaw0103 physical sciencesGeneral Physics and AstronomyResonance010306 general physicsCollider01 natural scienceslaw.inventionLuminosityPhysical Review Letters
researchProduct

Search for B+→K+νν¯ Decays Using an Inclusive Tagging Method at Belle II

2021

A search for the flavor-changing neutral-current decay B^{+}→K^{+}νν[over ¯] is performed at the Belle II experiment at the SuperKEKB asymmetric energy electron-positron collider. The data sample corresponds to an integrated luminosity of 63 fb^{-1} collected at the ϒ(4S) resonance and a sample of 9 fb^{-1} collected at an energy 60 MeV below the resonance. Because the measurable decay signature involves only a single charged kaon, a novel measurement approach is used that exploits not only the properties of the B^{+}→K^{+}νν[over ¯] decay, but also the inclusive properties of the other B meson in the ϒ(4S)→BB[over ¯] event, to suppress the background from other B meson decays and light-qua…

PhysicsParticle physicsLuminosity (scattering theory)010308 nuclear & particles physicsBranching fractionElectron–positron annihilationGeneral Physics and AstronomyResonance01 natural scienceslaw.inventionPair productionlaw0103 physical sciencesHigh Energy Physics::ExperimentB meson010306 general physicsColliderEnergy (signal processing)Physical Review Letters
researchProduct

The Belle II Physics Book

2019

cd. autorów: L. Cao48,‡, G. Caria145,‡, G. Casarosa57,‡, C. Cecchi56,‡,D. Cˇ ervenkov10,‡,M.-C. Chang22,‡, P. Chang92,‡, R. Cheaib146,‡, V. Chekelian83,‡, Y. Chen154,‡, B. G. Cheon28,‡, K. Chilikin77,‡, K. Cho70,‡, J. Choi14,‡, S.-K. Choi27,‡, S. Choudhury35,‡, D. Cinabro170,‡, L. M. Cremaldi146,‡, D. Cuesta47,‡, S. Cunliffe16,‡, N. Dash33,‡, E. de la Cruz Burelo9,‡, E. de Lucia52,‡, G. De Nardo54,‡, †Editor. ‡Belle II Collaborator. §Theory or external contributing author. M. De Nuccio16,‡, G. De Pietro59,‡, A. De Yta Hernandez9,‡, B. Deschamps129,‡, M. Destefanis60,‡, S. Dey116,‡, F.Di Capua54,‡, S.Di Carlo75,‡, J. Dingfelder129,‡, Z. Doležal10,‡, I. Domínguez Jiménez125,‡, T.V. Dong30,26,…

B: semileptonic decayPhysics beyond the Standard ModelHadronelectroproduction [charmonium]General Physics and AstronomyComputingMilieux_LEGALASPECTSOFCOMPUTINGB: radiative decayannihilation [electron positron]7. Clean energy01 natural sciencescharmonium: electroproductionB physicsHigh Energy Physics - Experimentlaw.inventionHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)Z'law[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Charm (quantum number)dark sector searchesPhysicslifetimeradiative decay [B]doublet [Higgs particle]new physicsPhysicsHigh Energy Physics - Lattice (hep-lat)ddc:530Electroweak interactionlepton: flavor: violationhep-phParticle Physics - LatticeMonte Carlo [numerical calculations]electron positron: colliding beamsQuarkoniumasymmetry: CPquarkonium physicselectroweak interaction: penguinHigh Energy Physics - PhenomenologyImproved performancecolliding beams [electron positron]CP violationinterfaceelectroproduction [quarkonium]electroweak precision measurementsnumerical calculations: Monte CarlophysicsParticle Physics - ExperimentperformanceParticle physicsflavor: violation [lepton]reviewhep-latFOS: Physical sciencesBELLEHigh Energy Physics - Experiment; High Energy Physics - Experiment; High Energy Physics - Lattice; High Energy Physics - Phenomenologyelectron positron: annihilationquarkonium: electroproductionCP [asymmetry]E(6)Higgs particle: doubletmixing [D0 anti-D0]Theoretical physicsCP: violation: time dependenceHigh Energy Physics - LatticeKEK-B0103 physical sciencesquantum chromodynamicshidden sector [photon]ddc:530composite010306 general physicsColliderParticle Physics - PhenomenologyHigh Energy Physics - Experiment; High Energy Physics - Lattice; High Energy Physics - Phenomenologyphoton: hidden sectorhep-ex010308 nuclear & particles physics[PHYS.HLAT]Physics [physics]/High Energy Physics - Lattice [hep-lat]C50 Other topics in experimental particle physicsviolation: time dependence [CP]D0 anti-D0: mixingB2TiP530 PhysikExperimental physicsB: leptonic decayCKM matrix[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]penguin [electroweak interaction]leptonic decay [B]semileptonic decay [B]charmparticle identificationexperimental results
researchProduct

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

2021

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

MaleCOVID-19 Vaccinesafe surgery; vaccination modelling; COVID-19Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]MULTICENTERComorbidity030230 surgery0302 clinical medicinephase 3 clinical trial (topic)Case fatality rateProspective StudiesSARS-CoV-2 Vaccination Safe surgeryCOVID-19/epidemiologySARS-CoV-2 ; vaccination ; safe surgeryeducation.field_of_studycase fatality rateVaccinationVaccinationAdolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Prospective Studies; SARS-CoV-2; Vaccination; Young Adulthealth care policyElective Surgical Procedures030220 oncology & carcinogenesisvaccination modellingPreoperative PeriodCOVID-19; SARS-CoV-2; cancer; vaccination; outcome; mortality; infection; modellingCohort studyprospective studyHumanmedicine.medical_specialtyArticle03 medical and health sciencesSARS-CoV-2 vaccinationSDG 3 - Good Health and Well-beingCOVID-19 Vaccines/pharmacologyHumansVaccination/methodsElective surgeryeducationAgedScience & TechnologyElective Surgical Procedureadult; aged; Article; cancer grading; cancer surgery; case fatality rate; computer assisted tomography; elective surgery; female; follow up; health care policy; human; incidence; infection rate; infection risk; major clinical study; male; middle aged; mortality; outcome assessment; phase 3 clinical trial (topic); preoperative care; prospective study; sensitivity analysis; seroprevalence; Severe acute respiratory syndrome coronavirus 2; vaccination; young adult; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Postoperative Complications; Preoperative Period; SARS-CoV-2; Vaccination; surgery.Cura preoperatòriamajor clinical studymortalityinfectionProspective StudieincidenceSurgeryHuman medicinePostoperative Complication610 Medizin und GesundheitAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALEcomputer assisted tomographyESTUDOS PROSPECTIVOSsurgerysafe surgeryPostoperative Complicationssensitivity analysisSevere acute respiratory syndrome coronavirus 2preoperative careVacunacióProspective cohort studyseroprevalenceIncidence (epidemiology)covidElective Surgical Procedures/methodsMiddle Agedcancer gradingCOVID vaccinationoutcome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSARS-CoV-2; vaccination; surgeryOriginal ArticleFemalecancer surgeryAcademicSubjects/MED00010Life Sciences & BiomedicineAdultCOVID-19 VaccinesAdolescentinternational prospective cohort studyPostoperative Complications/prevention & controlPopulationinfection rateSARS-CoV-2/immunologyNOmodellingYoung Adultmedicinefollow upcancerddc:610infection riskoutcome assessmentLS7_4business.industrySARS-CoV-2Number needed to vaccinatePreoperative careCOVID-193126 Surgery anesthesiology intensive care radiologySettore MED/18Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]elective surgeryEmergency medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe British Journal of Surgery
researchProduct

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Resear…

2021

Abstract Background Epidemiological studies in atrial fibrillation (AF) illustrate that clinical complexity increase the risk of major adverse outcomes. We aimed to describe European AF patients’ clinical phenotypes and analyse the differential clinical course. Methods We performed a hierarchical cluster analysis based on Ward’s Method and Squared Euclidean Distance using 22 clinical binary variables, identifying the optimal number of clusters. We investigated differences in clinical management, use of healthcare resources and outcomes in a cohort of European AF patients from a Europe-wide observational registry. Results A total of 9363 were available for this analysis. We identified three …

RegistrieResearch Reportmedicine.medical_specialtyMajor adverse outcomeCardiovascular risk factorsCluster analysisRisk FactorsInternal medicineClinical phenotypeAtrial FibrillationEpidemiologyHumansMedicineRegistriesCluster analysiAtrial fibrillation; Clinical management; Clinical phenotypes; Cluster analysis; Major adverse outcomes; Humans; Phenotype; Registries; Research Report; Risk Factors; Atrial FibrillationClinical managementbusiness.industryProportional hazards modelRisk FactorHazard ratioRAtrial fibrillationClinical phenotypesMajor adverse outcomesGeneral Medicinemedicine.diseaseAtrial fibrillationConfidence intervalPhenotypeCohortMedicineObservational studybusinessResearch ArticleHumanBMC Medicine
researchProduct